DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Eli Lilly and Company
LLY
-
US5324571083
Compare
Last update : Aug 11, 2026 at 12:25
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Eli Lilly and Company (LLY) Business Breakdown and KPIs - Invvest
Settings
Period
5 years
10 years
Max
Customization
Line
Bar
Percentage
Value
Labels
Growth YoY
Sections
Segments
KPIs
Segments
Revenue
Baqsimi Revenue
Glucagon Revenue
Cardiovascular Revenue
Oncology Revenue
Other Cardiometabolic Health Revenue
Trulicity Revenue
Others
CAGR
Variation 10 years
Baqsimi Revenue
+0.72%
+7.46%
Glucagon Revenue
+2.03%
+22.2%
Cardiovascular Revenue
+2.6%
+29.25%
Oncology Revenue
+1.66%
+17.88%
Other Cardiometabolic Health Revenue
-0.35%
-3.44%
Trulicity Revenue
+0.26%
+2.59%
Others
-0.33%
-3.21%
Revenue by Geography
Europe Revenue
Japan Revenue
Other Foreign Countries Revenue
China Revenue
US Revenue
CAGR
Variation 10 years
Europe Revenue
+3.06%
+35.2%
Japan Revenue
+2%
+21.89%
Other Foreign Countries Revenue
-0.93%
-8.89%
China Revenue
-2.08%
-18.97%
US Revenue
-0.08%
-0.78%
KPIs
Revenue Change due to Price
Revenue Change due to Price
CAGR
Variation 10 years
Revenue Change due to Price
-1.25%
-11.8%
Revenue Change due to Volume
Revenue Change due to Volume
CAGR
Variation 10 years
Revenue Change due to Volume
+1.49%
+15.89%
Revenue Change due to FX
Revenue Change due to FX
CAGR
Variation 10 years
Revenue Change due to FX
+0.75%
+7.79%
